By Catherine Eckford2024-04-26T16:41:45
A study has demonstrated how 3D printing can be used to manufacture tailored, safe, and effective treatments for patients with rare diseases via pharmaceutical compounding.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-22T14:48:00Z
Sponsored by CPhI
2026-05-21T08:24:00Z
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-07-10T12:58:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
2026-04-14T12:32:00
Sponsored by Thermo Fisher Scientific
2025-11-05T15:00:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
2025-12-11T13:32:00
Sponsored by Hexagon
Site powered by Webvision Cloud